PG Course-LV
Nov. 15 (Thu) 09:00-10:30	Recent progress in the management of chronic liver diseases	103
Chairperson(s)	Jidong Jia (Beijing), Jin Mo Yang (Seoul)
09:00-09:20	Strategies for complete cure of HBV infection beyond strong antiviral suppressive treatment	TBA
09:20-09:40	Update of pharmacological therapies in nonalcoholic fatty liver disease	David Q.-H. Wang (New York)
09:40-10:00	Recent updates in the management of cirrhosis complication: SBP, ascites and varix bleeding	Ashish Kumar (New Delhi)
10:00-10:20	Differences in HCC treatment strategies: Eastern vs Western Perspectives	Joong Won Park (Goyang)
10:20-10:30	Q&As

Sex and Gender Specific Medicine Session
Nov. 15 (Thu) 09:00-10:30	Sex and gender specific medicine	105
Chairperson(s)	Eamonn Quigley (Houston), Nayoung Kim (Seongnam)
09:00-09:20	Gender difference in gastrointestinal function and functional GI disorders	Hidekazu Suzuki (Tokyo)
09:20-09:40	Sex and gender specific IBS	Young Sun Kim (Seoul)
09:40-10:00	Gender, the microbiome and the microbiome-gut-brain axis	Eamonn Quigley (Houston)
10:00-10:20	Work-Life conflict and its health effects on Korean gastroenterologist according to age and sex	Eun Sun Jang (Seongnam)
10:20-10:30	Panel discussion

Joint Session between KDDW-TDDW-JDDW (LGI)
Nov. 15 (Thu) 09:00-10:30	Recent updates for therapeutic management of symptomatic bowel stricture in Crohn's disease: Asian experience and point of view	202
Chairperson(s)	Yoon Tae Jeen (Seoul), Cheng-Tang Chiu (Taoyuan City), Naoki Ohmiya (Toyoake)
Discusser(s)	TBA, TBA, TBA
09:00-09:20	Role of cross-sectional imaging in stricture differentiation: clinical implication for treatment strategy	TBA
09:20-09:40	Multidisciplinary approaches to bowel stricture in Crohn’s diseases	TBA
09:40-10:00	Endoscopic balloon dilation for small bowel strictures in Crohn’s disease by using double-balloon enteroscopy with calibrated small-caliber-tip transparent hood	Tomonori Yano (Shimotsukei)

Joint Session between KDDW-TDDW-JDDW (LGI)
Nov. 15 (Thu) 09:00-10:30	Rising star program-Lower G.I	202
Chairperson(s)	Yoon Tae Jeen (Seoul), Cheng-Tang Chiu (Taoyuan City), Naoki Ohmiya (Toyoake)
Discusser(s)	TBA, TBA, TBA
10:00-10:10	Effective colorectal cancer screening using FIT and clinical risk stratification	TBA
10:10-10:20	Endoscopic management of stricture in Crohn’s diseases in Taiwan	TBA
10:20-10:30	Application of artificial intelligence using convolutional neural network for detecting gastric cancer in endoscopic images	Toshiaki Hirasawa (Tokyo)

KDDW Symposium GI-1 (UG)
Nov. 15 (Thu) 09:00-10:30	Prevention of gastric cancer	203
Chairperson(s)	Sang Young Seol (Busan), Jae J. Kim (Seoul)
09:00-09:20	Primary prevention: role of H. pylori eradication	Kee Don Choi (Seoul)
09:20-09:40	Secondary prevention: role of H. pylori eradication after endoscopic resection of gastric epithelial neoplasia	Hiroto Miwa (Nishinomiya)
09:40-10:00	Secondary prevention: role of H. pylori eradication after partial gastrectomy	Da Hyun Jung (Seoul)
10:00-10:20	Chemoprevention of gastric cancer other than H. pylori eradication	Soo-Jeong Cho (Goyang)
10:20-10:30	Q&As

KDDW PG Course-PB (K)
Nov. 15 (Thu) 09:00-10:30	Recent advances and problems in the management of pancreatobiliary disease	E1+2
Chairperson(s)	Sang-Heum Park (Cheonan), TBA (TBA)
09:00-09:20	Pancreatobiliary maljunction: diagnostic criteria and proper management	TBA
09:20-09:40	Optimal management of intrahepatic duct stones	Chang Hwan Park (Gwangju)
09:40-10:00	Recent advances in the management of advanced pancreatic neuroendocrine tumor	Chang-Min Cho (Daegu)
10:00-10:20	Endoscopic management of biliary complication after liver transplantation	Jimin Han (Daegu)
10:20-10:30	Q&As

PG Course-PB
Nov. 15 (Thu) 11:00-12:30	Pancreatobiliary endoscopy in challenging situations	103
Chairperson(s)	Yong-Tae Kim (Seoul), Jin Hong Kim (Suwon)
11:00-11:20	Acute severe pancreatitis; Initial management, Indications, timing and therapeutic modalities for drainage	D. Nageshwar Reddy (Hyderabad)
11:20-11:40	Pancreatic cystic neoplasm; Differential diagnosis, management & surveillance	Young Deok Cho (Seoul)
11:40-12:00	Bile duct stones and complications; Indication, timing and role of EUS, ERCP and cholecystectomy	Masayuki Kitano (Hong Kong)
12:00-12:20	Cholangiocarcinoma; Diagnosis, staging and pre-operative tissue acquisition and stenting.	TBA
12:20-12:30	Q&As

KDDW Symposium LV-1 (K)
Nov. 15 (Thu) 11:00-12:30	Changing paradigms in the the management of chronic liver disease	105
Chairperson(s)	TBA (TBA), Han Chu Lee (Seoul)
11:00-11:20	Chronic hepatitis B in special situation(during pregnancy and immunospressive therapy)	Sae Hwan Lee (Cheonan)
11:20-11:40	Chronic hepatitis C in serious cases(renal insufficiency, decompensated cirrhosis and HCC)	Hana Park (Seongnam)
11:40-12:00	Severe alcoholic hepatitis in alcoholic liver disease	Eileen Laurel Yoon (Busan)
12:00-12:20	Non-alcoholic steatohepatitis ;Current and future treatment options	Hwi Young Kim (Seoul)
12:20-12:30	Q & A

KDDW Combined-1 (Nutrition)
Nov. 15 (Thu) 11:00-12:30	Optimal nutritional support in various clinical situations	201
Chairperson(s)	Geun Am Song (Yangsan), Hyun Wook Baik (Seongnam), Byung-Ho Choe (Daegu)
11:00-11:20	Perioperative period: enteral and parenteral nutrition	Hyuk-Joon Lee (Seoul)
11:20-11:40	Gastrointestinal cancer patients who are not candidates for surgery: when to treat and when to stop	Dong Kyung Chang (Seoul)
11:40-12:00	Chronic pancreatitis: the timing of nutritional intervention and therapeutic goal	Min Kyu Jung (Daegu)
12:00-12:20	Inflammatory bowel disease: nutrition in acute exacerbation and as long-term care	Jin Young Yoon (Seoul)
12:20-12:30	Q&As

Joint Session between KDDW-TDDW-JDDW (PB)
Nov. 15 (Thu) 11:00-12:30	Optimal palliation for malignant biliary obstruction: Asian experiences and best practice	202
Chairperson(s)	TBA (TBA), Hsiu-Po Wang (Taipei City), Masafumi Nakamura (Fukuoka)
Discusser(s)	Kyo-Sang Yoo (Guri), Chieh-Chang Chen (Taipei City), TBA
11:00-12:00	Current status of biliary metal stents	Don Haeng Lee (Incheon)
11:00-12:00	Current evidence of palliation for malignant biliary obstruction	Wei-Chih Liao (Taipei City)
11:00-12:00	Best practice for malignant biliary obstruction: a surgeon's veiwpoint	Itaru Endo (Yokohama)

Joint Session between KDDW-TDDW-JDDW (PB)
Nov. 15 (Thu) 11:00-12:30	Rising star program-Biliary, pancreas	202
Chairperson(s)	TBA (TBA), Hsiu-Po Wang (Taipei City), Masafumi Nakamura (Fukuoka)
Discusser(s)	Kyo-Sang Yoo (Guri), Chieh-Chang Chen (Taipei City), TBA
12:00-12:30	Diagnosis and Management of Pancratic Cancer in Korean Population	TBA
12:00-12:30	Endoscopic palliation for malignant biliary obstruction: Taiwan experience	TBA
12:00-12:30	Mesenteric approach during pnacreaticoduodenectomy for pancreatic cancer	TBA

KDDW Symposium GI-2 (Motility)
Nov. 15 (Thu) 11:00-12:30	Dyspepsia: what’s new in 2018? (ANMA-KSNM joint session)	203
Chairperson(s)	Hyo Jin Park (Seoul), Oh Young Lee (Seoul)
11:00-11:20	Epidemiology of functional dyspepsia in Asia	Hyo Jin Park (Seoul)
11:20-11:40	New pathogenesis of functional dyspepsia	Kwang Jae Lee (Suwon)
11:40-12:00	Helicobacter pylori-associated dyspepsia	Kentaro Sugano (Shimotsukei)
12:00-12:20	Novel treatment of dyspepsia	Justin C.Y. Wu (Hong Kong)
12:20-12:30	Q&As

KDDW PG Course-GI Cancer (K)
Nov. 15 (Thu) 11:00-12:30	Update and change of health insurance coverage for gastrointestinal cancer in Korea 2018	E1+2
Chairperson(s)	Kwang Ro Joo (Seoul), Sung-Soo Kim (Uijeongbu)
11:00-11:20	Esophageal / stomach cancer	Hee Seok Moon (Daejeon)
11:20-11:40	Colorectal cancer	Jae Jun Park (Seoul)
11:40-12:00	Pancreatobiliary cancer	Sang Myung Woo (Goyang)
12:00-12:20	Palliative care for gastrointestinal cancer - pain, anti-emetics, nutrition	Jin Seok Jang (Busan)
12:20-12:30	Q&As

PG Course-UG
Nov. 15 (Thu) 14:00-15:30	Overview of recent progress in upper GI diseases	103
Chairperson(s)	Jaw-Town Lin (Taipei), Soo-Heon Park (Seoul)
14:00-14:20	Diagnosis and treatment of GERD	Sabine Roman (Lyon)
14:20-14:40	Management of peptic ulcer disease	Joseph JY Sung (Hong Kong)
14:40-15:00	Helicobacter pylori eradication in Asia-Pacific regions	Jaw-Town Lin (Taipei)
15:00-15:20	Effect of screening endoscopy for gastric cancer in regions where Helicobacter pylori is prevalent	TBA
15:20-15:30	Q&As

KDDW Symposium LV-2 (K)
Nov. 15 (Thu) 14:00-15:30	General review of rare liver diseases	105
Chairperson(s)	Kwan Soo Byun (Seoul), TBA (TBA)
14:00-14:20	Wilson's disease	Hyun Chin Cho (Jinju)
14:20-14:40	Autoimmune hepatitis	Yang Hyun Baek (Busan)
14:40-15:00	Primary biliary cholangitis	Hee Yeon Kim (Seoul)
15:00-15:20	Portal vein thrombosis	Nae Yun Heo (Busan)
15:20-15:30	Q & A

KDDW Combined-2 (UGI-LGI)
Nov. 15 (Thu) 14:00-15:30	NSAIDs-induced GI injury	201
Chairperson(s)	Wai-keung Leung (Hong Kong), Young Sook Park (Seoul)
14:00-14:20	Pathophysiology	Jaeyoung Chun (Seoul)
14:20-14:40	NSAIDs-associated upper GI disease	TBA
14:40-15:00	NSAIDs-associated lower GI disease	Wai-keung Leung (Hong Kong)
15:00-15:20	Prevention and treatment	Seong Woo Jeon (Daegu)
15:20-15:30	Q&As

Joint Session between KDDW-TDDW-JDDW (UGI)
Nov. 15 (Thu) 14:00-15:30	Population based eradication strategy for Helicobacter pylori infection; Progress and perspectives in Asian countries	202
Chairperson(s)	Jae Gyu Kim (Seoul), Ming-Shiang Wu (Taipei City), Toshiro Sugiyama (Toyama)
Discusser(s)	Byung-Wook Kim (Incheon), TBA, Kiichi Satoh (Tokyo)
14:00-14:20	The Korean perspective of Helicobacter pylori eradication	Nayoung Kim (Seoul)
14:20-14:40	Mass eradication of Helicobacter pylori infection for gastric cancer prevention in Taiwan	TBA
14:40-15:00	Nationwide eradication strategy for Helicobacter pylori infection in Japan	Hidekazu Suzuki (Tokyo)

Joint Session between KDDW-TDDW-JDDW (UGI)
Nov. 15 (Thu) 14:00-15:30	Rising star program-Upper G.I.	202
Chairperson(s)	Jae Gyu Kim (Seoul), Ming-Shiang Wu (Taipei City), Toshiro Sugiyama (Toyama)
Discusser(s)	Byung-Wook Kim (Incheon), TBA, Kiichi Satoh (Tokyo)
15:00-15:10	Helicobacter pylori infection in Korea	TBA
15:10-15:20	Toward population specific and personalized treatment of Helicobacter pylori infection in Taiwan	TBA
15:20-15:30	The recent argument of gastric ESD	TBA

KDDW Special Lecture
Nov. 15 (Thu) 14:00-15:30	KDDW Special Lecture	205B
Chairperson(s)	Dong Ki Lee (Seoul), TBA (TBA)

KDDW PG Course-Motility (K)
Nov. 15 (Thu) 14:00-15:30	변비 완전 정복 (A to Z of constipation)	E1+2
Chairperson(s)	Sei Jin Youn (Cheongju), Joon Seong Lee (Seoul)
14:00-14:20	병태생리 (Pathophysiology)	TBA
14:20-14:40	진단 (Assessment)	Joon Seong Lee (Seoul)
14:40-15:00	약물치료 (Pharmacologic treatment)	Kee Wook Jung (Seoul)
15:00-15:20	비약물치료 (Nonpharmacologic treatment)	Tae Hee Lee (Seoul)
15:20-15:30	Q&As

PG Course-LG
Nov. 15 (Thu) 16:00-17:30	Recent update in lower GI diseases	103
Chairperson(s)	Peter R. Gibson (Melbourne), Tae Il Kim (Seoul)
15:20-15:30	Q&As
16:00-16:20	The cutting edge strategy for the treatment of inflammatory bowel disease therapy	Choon-jin Ooi (Singapore)
16:20-16:40	Quality issues in colonoscopic screening for colorectal cancer	Uri Ladabaum (Stanford)
16:40-17:00	Treatment of IBD: low-FODMAP diet and beyond	Peter R. Gibson (Melbourne)
17:00-17:20	Upates in diagnosis and treatment for Clostridium difficile infection	You Sun Kim (Seoul)

KDDW Symposium LV-3 (K)
Nov. 15 (Thu) 16:00-17:30	Management of cormobidity in liver disease	105
Chairperson(s)	TBA (TBA), Joon Hyoek Lee (Seoul)
16:00-16:20	Geneal and liver specific management of hypertension	TBA
16:20-16:40	Geneal and liver specific selection of antibotics and vaccine	TBA
16:40-17:00	Geneal and liver specific management of obesity	TBA
17:00-17:20	Geneal and liver specific management of psychiatric disorder	Jung Seok Choi (Seoul)
17:20-17:30	Q & A

Joint Session between KDDW-TDDW-JDDW (Liver)
Nov. 15 (Thu) 16:00-17:30	Upcoming NAFLD in Asia: The current status and practice points in Asia Pacific region	202
Chairperson(s)	TBA (TBA), Jia-Horng Kao (Taipei), Takeshi Okanoue (Suita)
Discusser(s)	Joo Hyun Sohn (Guri), TBA, Kenichi Ikejima (Tokyo)
16:00-16:20	Increasing disease burden of NAFLD in Asia Pacific region: How to connect between Hepatologist, Endocrinologist and primary care	TBA
16:20-16:40	Impact of NAFLD on clinical outcome of viral hepatitis in Asia Pacific region	Ching-Sheng Hsu (New Taipei)
16:40-17:00	Characteristic features of NAFLD in Japan with a focus on the role of gender and obesity	Etsuko Hashimoto (Tokorozawa-shi)

Joint Session between KDDW-TDDW-JDDW (Liver)
Nov. 15 (Thu) 16:00-17:30	Rising star program-Liver	202
Chairperson(s)	TBA (TBA), Jia-Horng Kao (Taipei), Takeshi Okanoue (Suita)
Discusser(s)	Joo Hyun Sohn (Guri), TBA, Kenichi Ikejima (Tokyo)
17:00-17:10	Exosomes derived from hepatocyte induce NAFLD associated fibrosis	Young-Sun Lee (Seoul)
17:10-17:20	Decoding differentiation cues in fatty infiltration and fatty liver disease	Feng-Chiao Tsai (Taipei)
17:20-17:30	Novel clinical strategy utilizing elastography to measure liver stiffness in patients with NAFLD -the dawning era of Hepatology-	TBA

KDDW Symposium GI-3 (LG)
Nov. 15 (Thu) 16:00-17:30	Recent progress on translational research in colorectal neoplasm	203
Chairperson(s)	Yoon Tae Jeen (Seoul), Joseph JY Sung (Hong Kong)
15:20-15:30	Q&As
16:00-16:20	Novel biomarkers of noninvasive diagnosis of colorectal cancer: Fecal microbiota	Joseph JY Sung (Hong Kong)
16:20-16:40	Optimal strategy of colorectal cancer screening in Asia	TBA
16:40-17:00	Emerging imaging techniques for colorectal neoplasm	Seung-Jae Myung (Seoul)
17:00-17:20	New targeting agents for treatment of colorectal neoplasm	TBA

KDDW PG Course-UG (K)
Nov. 15 (Thu) 16:00-17:30	PG Course-UG (K)	E1+2
Chairperson(s)	Jong Sun Rew (Gwangju), TBA (TBA)
15:20-15:30	Q&As
16:00-16:20	소화성궤양 합병증: 어떻게 대처할 것인가?	Ju Yup Lee (Daegu)
16:20-16:40	조기위암의 내시경적 절제술: 그 다음 이야기	Wansik Lee (Gwangju)
16:40-17:00	불응성 역류성 식도염: 무엇을 더 해야 하나?	Moo In Park (Busan)
17:00-17:20	위축성위염, 장상피화생, 그리고 이형성: 단계별 추적검사	Woo Chul Chung (Suwon)

Symposium EN-1 (UG)
Nov. 16 (Fri) 08:30-10:00	Minimal invasive therapy of early gastric cancer: from ESD to surgery	101
Chairperson(s)	Hyung-Ho Kim (Seongnam), Enqiang Linghu (Beijing)
08:30-08:50	How to choose a patient with early gastric cancer who can be treated with endoscopic submucosal dissection	Enqiang Linghu (Beijing)
08:50-09:10	ESD for early gastric cancer with undifferentiated histology: do we have enough data?	Takuji Gotoda (Tokyo)
09:10-09:30	Risk stratification of noncurative ESD: do all patient need additional treatment?	Jun Chul Park (Seoul)
09:30-09:50	Sentinel node navigation surgery for early gastric cancer: when and how to perform?	Masanori Terashima (Shizuoka)
09:50-10:00	Q&As

Symposium EN-2 (LG)
Nov. 16 (Fri) 08:30-10:00	Progress in the detection and management of colorectal neoplasm	102
Chairperson(s)	Hermann Brenner (Heidelberg), TBA (TBA)
08:30-08:50	Image enhanced endoscopy in colorectal cancer screening: current status	Wai-keung Leung (Hong Kong)
08:50-09:10	Computer-aided detection and histopathology prediction for colorectal polyps	Jeong-sik Byeon (Seoul)
09:10-09:30	Detection and removal of serrated lesions	Hyo Joon Yang (Seoul)
09:30-09:50	Recent advances in colorectal ESD	Takahisa Matsuda (Tokyo)
09:50-10:00	Q&As

Symposium LV-1
Nov. 16 (Fri) 08:30-10:00	Chronic hepatitis B: current medication	103
Chairperson(s)	TBA (TBA), George KK Lau (Hong Kong)
08:30-08:50	Can we stop the neucleot(s)ide analogue?	George KK Lau (Hong Kong)
08:50-09:10	Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination	Henry LY Chan (Hong Kong)
09:10-09:30	HBV and HCV coinfection	Jidong Jia (Beijing)
09:30-09:50	Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long	Seng-Gee Lim (Singapore)
09:50-10:00	Q&As

Symposium PB-1
Nov. 16 (Fri) 08:30-10:00	New insights in the biliary system	104
Chairperson(s)	D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing)
08:30-08:50	Optimal evaluation of premalignant biliary lesions	TBA
08:50-09:10	Optimal approach to the indeterminate bile duct stricture	Hsiu-Po Wang (Taipei)
09:10-09:30	Updates on difficult biliary stones management	Amit Maydeo (Mumbai)
09:30-09:50	Best Endoscopic drainage of biliary system	Shutian Zhang (Beijing)
09:50-10:00	Q&As

Symposium GI-1 (Motility)
Nov. 16 (Fri) 08:30-10:00	Updates in gastrointestinal neurogastro-motility disorders	105
Chairperson(s)	Nicholas Talley (Callaghan), Kwang Jae Lee (Suwon)
08:30-08:50	Approach to esophageal disorders	John E. Pandolfino (Chicago)
08:50-09:10	Approach to gastric disorders	Nicholas Talley (Callaghan)
09:10-09:30	Approach to bowel disorders	Eamonn Quigley (Houston)
09:30-09:50	Differences of guidelines between Asia and West	TBA
09:50-10:00	Q&As

SIDDS 1
Nov. 16 (Fri) 08:30-10:00	Understanding of molecular alteration: the cornerstone for treatment of GI cancer	202
Chairperson(s)	James Goldenring (Nashville), Seung Woo Park (Seoul)
08:30-08:55	The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis	James Goldenring (Nashville)
08:55-09:20	Proteomic Multi-Marker Panel for Early Detection of GI cancers Using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)	Youngsoo Kim (Seoul)
09:20-09:45	Control of GI cancer using CRIPR-Cas9	Hyongbum Kim (Seoul)
09:40-10:00	Q&As

Symposium EN-3 (UG)
Nov. 16 (Fri) 08:30-10:00	Recent update in treatment for GI subepithelial tumors	203
Chairperson(s)	TBA (TBA), Seigo Kitano (Tokyo)
08:30-08:50	Resection for subepithelial tumors: when is it needed?	Jie-Hyun Kim (Seoul)
08:50-09:10	Endoscopic resection of subepithelial tumors via standard EMR/ESD technique	TBA
09:10-09:30	Endoscopic full thickness resection of subepithelial tumors	Chan Gyoo Kim (Goyang)
09:30-09:50	Minimally invasive surgery for subepithelial tumors	Osamu Goto (Tokyo)
09:50-10:00	Q&As

KDDW PG Course-LV (K)
Nov. 16 (Fri) 08:30-10:00	Concerning points and management during treatment for liver disease	E1+2
Chairperson(s)	TBA (TBA), So Young Kwon (Seoul)
08:30-08:50	During antiviral therapy for HBV	Hyun Phil Shin (Daejeon )
08:50-09:10	During antiviral therapy for HCV	In Hee Kim (Jeonju)
09:10-09:30	During imunosuppressive therapy for Autoimmune liver disease	TBA
09:30-09:50	During systemic therapy for HCC	Sung-Bum Cho (Gwangju)
09:50-10:00	Q&As

Okuda Lectureship
Nov. 16 (Fri) 11:00-11:30	Okuda Lectureship	Auditorium
Chairperson(s)	Rakesh Aggarwal (Lucknow), Yung-sang Lee (Seoul)
11:00-11:30	Challenges of Hepatitis B in the Era of Antiviral Therapy	Henry LY Chan (Hong Kong)

Marshall & Warren Lectureship
Nov. 16 (Fri) 11:30-12:00	Marshall & Warren Lectureship	Auditorium
Chairperson(s)	Ian Roberts-Thomson (Adelaide), Hyun Chae Jung
11:30-12:00	Chemoprevention of Gastric Cancer by H. pylori Eradication and its Underlying Mechanism	Nayoung Kim (Seongnam)

SIDDS 2
Nov. 16 (Fri) 10:30-12:00	Host-microbiome interactions in Gut and Liver disease	202
Chairperson(s)	TBA (TBA), TBA (TBA)
10:30-10:50	The gut microbiota in health and gastrointestinal diseases	Jong Sik Chun (Seoul)
10:50-11:10	The innate immune capacity of macrophages in regulation of intestinal barrier function and inflammation	Eunok Im (Iksan)
11:10-11:30	T cells and immunoregulatory cytokines in intestinal inflammation: implication on IBD treatment	Takanori Kanai (Tokyo)
11:30-11:50	Gut-liver axis in Liver diseases	TBA
11:50-12:00	Q&As

KDDW PG Course-Endoscopy (K)
Nov. 16 (Fri) 10:30-12:00	Basic drainage technique of Pancreatobiliary diseases (PG course)	E1+2
Chairperson(s)	Sang-Heum Park (Cheonan), TBA (TBA)
10:30-10:50	Biliary drainage: benign and malignant distal biliary obstruction	TBA
10:50-11:10	Biliary drainage: advanced hilar obstruction	Tae Hoon Lee (Cheonan)
11:10-11:30	Obstructed pancreatic duct drainage: transpapillary and EUS-guided drainage	Se Woo Park (Dongtan)
11:30-11:50	Gallbladder drainage: transpapillary and transmural drainage	TBA
11:50-12:00	Q&As

Symposium GI-2 (UG)
Nov. 16 (Fri) 14:00-15:30	Gastric carcinogenesis: Host, microbiome, and their interactions	101
Chairperson(s)	Kwong-ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20	Identification of genetic susceptibility for gastric cancer through genome-wide association studies	Benjamin Wong (Hong Kong)
14:20-14:40	Non-coding RNA and gastric cancer	Sang Kil Lee (Seoul)
14:40-15:00	Interactions between human and Helicobacter pylori in gastric carcinogenesis	Richard Peek (Nashville)
15:00-15:20	Non-Helicobacter pylori microbiome in gastric carcinogenesis	Yoshio Yamaoka (Oita)
15:20-15:30	Q&As

Symposium EN-4 (UG)
Nov. 16 (Fri) 14:00-15:30	Recent advances of EUS: one more step	102
Chairperson(s)	Laurent Palazzo (Paris), Dong Wan Seo (Seoul)
14:00-14:20	Enhanced EUS imaging: Elastography and contrast enhanced EUS	Laurent Palazzo (Paris)
14:20-14:40	EUS-FNA/FNB in the UGI tract: When and how?	Rungsun Reknimitr (Bangkok)
14:40-15:00	Present status of EUS in pancreatic cystic lesions	Yousuke Nakai (Tokyo)
15:00-15:20	Interpretation of EUS-FNA/FNB specimen: Pathologist’s view	Kee-Taek Jang (Seoul)
15:20-15:30	Q&As

Symposium LV-2
Nov. 16 (Fri) 14:00-15:30	Chronic hepatitis B: future treatment for the cure	103
Chairperson(s)	Seung Woon Paik (Seoul), Shiv K. Sarin (New Delhi)
14:00-14:20	Potential therapeutic target in hepatitis B virus life cycle	Jia-Horng Kao (Taipei)
14:20-14:40	New antiviral strategy to?combat with cccDNA and hepato-carcinogenesis	TBA
14:40-15:00	Immunologic modulation for hepatitis B treatment	Antonio Bertoletti (Singapore)
15:00-15:20	Emerging drugs?& new therapeutic perspectives?for HBV	Henry LY Chan (Hong Kong)
15:20-15:30	Q&As

Symposium PB-2
Nov. 16 (Fri) 14:00-15:30	Cutting edge of pancreatic diseases	104
Chairperson(s)	Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei)
14:00-14:20	Updates on the management of severe acute pancreatitis	Chengwei Tang (Chengdu)
14:20-14:40	Pancreatic enzyme replacement therapy in chronic pancreatitis	TBA
14:40-15:00	Updates on Ig G4 related diseases	Kazuichi Okazaki (Osaka)
15:00-15:20	Current status of pancreatic cystic neoplasm management	Aiming Yang (Beijing)
15:20-15:30	Q&As

Combined-1 (Liver, PB)
Nov. 16 (Fri) 14:00-15:30	Autoimmune diseases of the liver and biliary system: the essentials	105
Chairperson(s)	Myung-Hwan Kim (Seoul), Sook-Hyang Jeong (Seongnam)
14:00-14:20	Autoimmune hepatitis - 2018 Update	Atsushi Tanaka (Tokyo)
14:20-14:40	Primary biliary cholangitis: from diagnosis to treatment	Kyung -Ah Kim (Goyang)
14:40-15:00	Primary sclerosing cholangitis: what is the best management in the 21stcentury?	Hiroyuki Isayama (Tokyo)
15:00-15:20	IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat	Tae Jun Song (Seoul)
15:20-15:30	Q&As

Symposium GI-3 (LG)
Nov. 16 (Fri) 14:00-15:30	Shifting paradigm in IBD management	202
Chairperson(s)	Joo Sung Kim (Seoul), Siew C Ng (Hong Kong)
14:00-14:20	New drugs on the horizon: Targeting cytokines, cell trafficking, and more	Choon-jin Ooi (Singapore)
14:20-14:40	Fecal microbiota transplantation for IBD: Ready to use?	Siew C Ng (Hong Kong)
14:40-15:00	Toward improving quality of care in IBD management	David T Rubin (Chicago)
15:00-15:20	Things you should know when managing elderly IBD patients	Jae Hee Cheon (Seoul)
15:20-15:30	Q&As

Symposium EN-5 (UG)
Nov. 16 (Fri) 14:00-15:30	Current status and future direction for early esophageal cancer treatment strategy	203
Chairperson(s)	Joo Young Cho (Seongnam), Tsuneo Oyama (Saku)
14:00-14:20	High magnification and NBI imaging endoscopy for early esophageal cancer	Gwang Ha Kim (Yangsan)
14:20-14:40	ESD with multimodal treatment for esophageal cancer	Tsuneo Oyama (Saku)
14:40-15:00	Ablation therapy for esophageal cancer: when and how?	TBA
15:00-15:20	Management of esophageal stricture after endoscopic treatment	Yang Won Min (Seoul)
15:20-15:30	Q&As

Symposium GI-7 (GI Cancer) (K)
Nov. 16 (Fri) 14:00-15:30	Gastirc cancer, are we in new era for management?	E1+2
Chairperson(s)	Hyun Yong Jeong (Daejeon ), James Goldenring (Nashville), Moon Soo Lee (Cheonan)
14:00-14:20	The global change in epidemiology of gastric cancer	Jin Young Park (Lyon)
14:20-14:40	Role of?SPEM in gastric carcinogenesis	James Goldenring (Nashville)
14:40-15:00	Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery?	Keun Won Ryu (Goyang)
15:00-15:20	Current treatment landscape and future perspectives in patients with advanced gastric cancer	Sung Eun Kim (Busan)
15:20-15:30	Q&As

AGA-APAGE
Nov. 16 (Fri) 16:00-18:00	From bench to clinic in gastric cancer: Where are we headed?	101
Chairperson(s)	Emad El-Omar (Kogarah), Sang Woo Lee (Seoul)
16:00-16:25	The molecular pathogenesis of gastric cancer ? state of the art	Timothy Wang (New York)
16:25-16:50	The role of the gastric microbiome in H. pylori-induced gastric cancer	Richard Peek (Nashville)
16:50-17:15	Prevention of gastric cancer ? opportunities and potential problems	Kentaro Sugano (Shimotsukei)
17:15-17:40	National gastric cancer screening- outcomes and future challenges	Il Ju Choi (Goyang)
17:40-18:00	Q&As

Symposium GI-4 (LG)
Nov. 16 (Fri) 16:00-17:30	The cutting edge issues in management of IBD 2018	102
Chairperson(s)	Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20	What should be the therapeutic targets in IBD therapy?	Siew C Ng (Hong Kong)
16:20-16:40	Proper positioning of various drugs in therapeutic algorithm	David T Rubin (Chicago)
16:40-17:00	Place of TDM in optimal use of biologics	Akira Andoh (Shiga)
17:00-17:20	Managing Crohn's disease after surgery	Kang-Moon Lee (Suwon)
17:20-17:30	Q&As

Symposium LV-3
Nov. 16 (Fri) 16:00-17:30	Chronic hepatitis C in DAA era	103
Chairperson(s)	Kwan Soo Byun (Seoul), Rakesh Aggarwal (Lucknow)
16:00-16:20	HCV screening in general population: is this cost-effective in DAA era?	Rakesh Aggarwal (Lucknow)
16:20-16:40	Is there difficult to treat population in HCV patients in DAA era?	TBA
16:40-17:00	Chronic hepati+G313	Yasuhiro Asahina (Tokyo)
17:00-17:20	DAA first versus transplantation first in decompensated cirrhotic HCV patients	Young-Suk Lim (Seoul)
17:20-17:30	Q&As

WEO Honorary Lectureship
Nov. 16 (Fri) 16:00-17:00	WEO Honorary Lectureship	104
Chairperson(s)	TBA, TBA
16:00-16:50	Paving the way to the globalization of advanced endoscopy	Hisao Tajiri (Tokyo)
16:50-17:00	Q&A

Combined-2 (Endoscopy-Surgery)
Nov. 16 (Fri) 16:00-17:30	Gastrointestinal diseases and treatments in obese patients (KSGE combined session)	105
Chairperson(s)	TBA (TBA), Joo Ho Lee (Seoul)
16:00-16:20	Functional gastrointestinal disorders in obese patients	Yong Sung Kim (Iksan)
16:20-16:40	Gastrointestinal tumors associated with obesity	Jin-Hyeok Hwang (Seongnam)
16:40-17:00	Endoscopic treatments for morbid obesity	Hyuk Soon Choi (Seoul)
17:00-17:20	Surgical treatments for morbid obesity	Takeshi Naitoh (Sendai)
17:20-17:30	Q&As

Symposium GI-5 (UG)
Nov. 16 (Fri) 16:00-17:30	All about GIST on UGI tract	202
Chairperson(s)	TBA (TBA), Byung-Wook Kim (Incheon)
16:00-16:20	Pathologic diagnosis; focused on prognostic factor	TBA
16:20-16:40	Endoscopic treatment: when and how?	Hang Lak Lee (Seoul)
16:40-17:00	Surgical treatment: when and how?	Hyundong Chae (Daegu)
17:00-17:20	Target therapy: when and how?	Dong-Hoe Koo (Seoul)
17:20-17:30	Q&As

Symspoium PB-3
Nov. 16 (Fri) 16:00-17:30	Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing?	203
Chairperson(s)	Ho Soon Choi (Seoul), Ji-kon Ryu (Seoul), Dong-Sup Yoon (Seoul)
16:00-16:20	Pathogenesis and molecular characterization: from genetics to signaling pathways	Young Nyun Park (Seoul)
16:20-16:40	Pathologic classification: new concepts	Kyungbun Lee (Seoul)
16:40-17:00	Endoscopic management: from ERCP to EUS	Masayuki kitano (Wakayama)
17:00-17:20	Selection of patients for curative resection and role of surgery: from resection to transplantation	Masayuki Ohtsuka (Chiba)
17:20-17:30		Dong Hee Koh (Hwaseong)

KDDW PG Course-LG (K)
Nov. 16 (Fri) 16:00-17:30	Current status and future perspectives in management of small bowel diseases	E1+2
Chairperson(s)	Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20	Optimal approach to small bowel bleeding (소장 출혈의 원인과 진단)	TBA
16:20-16:40	Radiologic diagnosis of small bowel diseases (소장 질환의 영상학 진단)	TBA
16:40-17:00	Therapeutic role of enteroscopy (소장내시경의 소장 질환에서 치료 역할)	Sung Noh Hong (Seoul)
17:00-17:20	Interesting cases of various small bowel diseases (다양한 소장질환의 증례 소개 및 증례 관련 간단요약 - 역학/진단/치료)	TBA
17:20-17:30	Q&As

Symposium LV-4
Nov. 17 (Sat) 08:30-10:00	Current advances in non-alcoholic fatty liver disease	101
Chairperson(s)	Kwang Hyub Han (Seoul), George Jacob (Sydney)
08:30-08:50	New trends on obesity and NAFLD in Asia	Vincent Wong (Hong Kong)
08:50-09:10	Interactions between bile acids and nuclear receptors in NAFLD	David Q.-H. Wang (New York)
09:10-09:30	Clinical trial design and optimal endpoints for nonalcoholic steatohepatitis	Won Kim (Seoul)
09:30-09:50	Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease	George Jacob (Sydney)
09:50-10:00	Q&As

Symposium GI-6 (LG)
Nov. 17 (Sat) 08:30-10:00	Updates on the management of gastrointestinal bleeding	103
Chairperson(s)	Toshiyuki Matsui (Chikushino), Michael Li (Hong Kong), TBA (TBA)
08:30-08:50	Treatment of peptic ulcer bleeding: present and future	Philip Chiu (Hong Kong)
08:50-09:10	Diagnostic approach and management for obscure gastrointestinal bleeding	Ki-Nam Shim (Seoul)
09:10-09:30	Endoscopic management of colonic diverticular bleeding	Hiroshi Kashida (Osaka)
09:30-09:50	Treatment and prevention of Variceal bleeding	Shiv K. Sarin (New Delhi)
09:50-10:00	Q&As

Symposium EN-6 (PB)
Nov. 17 (Sat) 08:30-10:00	Pancreatobiliary endoscopy in challenging situations	104
Chairperson(s)	Dong Ki Lee (Seoul), Ari Fahrial Syam (Depok)
08:30-08:50	How to minimize ERCP complications	Hiroyuki Isayama (Tokyo)
08:50-09:10	Updates of cholangioscopy for the diagnosis and treatment of biliary tract cancer	Jong Ho Moon (Bucheon)
09:10-09:30	ERCP for patients with altered gastrointestinal anatomy	TBA
09:30-09:50	Endoscopic resecure management after surgical complications	TBA
09:50-10:00	Q&As

Symposium SM-1
Nov. 17 (Sat) 08:30-10:00	Multidisciplinary approach to perihilar cholangiocarcinoma	105
Chairperson(s)	Alfred Kow (Singapore), Ho Gak Kim (Daegu)
08:30-08:50	Diagnosis and intervention: radiologist's perspective	Jung Hoon Kim (Seoul)
08:50-09:10	Diagnosis and intervention: endoscopist's perspective	TBA
09:10-09:30	What is the adequate extent of surgery for Bismuth type I or II perihilar cholangiocarcinoma	Masayuki Ohtsuka (Chiba)
09:30-09:50	Extensive resection of perihilar cholangiocarcinoma	Dong Wook Choi (Seoul)
09:50-10:00	Q&As

Symposium EN-7 (LG)
Nov. 17 (Sat) 08:30-10:00	Early colorectal cancer: a smart approach and optimal treatment	202
Chairperson(s)	TBA (TBA), Takahisa Matsuda (Tokyo), Woo Yong Lee (Seoul)
08:30-08:50	Best approach for predicting deep SM invasion	Hyungun Kim (Seoul)
08:50-09:10	New device and advanced technique of colorectal ESD	Takahisa Matsuda (Tokyo)
09:10-09:30	Minimal invasive surgery for early colorectal cancer: Role and Future	Jin Kim (Seoul)
09:30-09:50	Optimal surveillance strategy for early colorectal cancer	TBA
09:50-10:00	Q&As

Symposium PB-4
Nov. 17 (Sat) 08:30-10:00	Gallbladder disease: unsolved problems revisited	203
Chairperson(s)	Jong Kyun Lee (Seoul), TBA (TBA)
08:30-08:50	What are the true risk factors and precursors to gallbladder cancer?	TBA
08:50-09:10	Differential diagnosis between gallbladder cancer and benign gallbladder disease	Mi-Suk Park (Seoul)
09:10-09:30	Endoscopic gallbladder drainage compared with percutaneous drainage: advantages and limitations	TBA
09:30-09:50	Surgical strategies for acute cholecystitis in the era of minimal invasive approach: when and how?	Keun Soo Ahn (Daegu)
09:50-10:00	Q&As

Emerging Leader Lectureship 1
Nov. 17 (Sat) 11:00-11:30	Emerging Leader Lectureship 1	Auditorium
Chairperson(s)	Khean-Lee Goh (Kuala Lumpur), Si Young Song (Seoul)
11:00-11:30	Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy	Yoshimasa Saito (Japan)

Emerging Leader Lectureship 2
Nov. 17 (Sat) 11:30-12:00	Emerging Leader Lectureship 2	Auditorium
Chairperson(s)	TBA (TBA), Jung-Hwan Yoon (Seoul)
11:30-12:00	Disease outcomes of chronic hepatitis B in the era of nucleoside analogue therapy	Wai-Kay Walter Seto (Hong Kong)

Symposium LV-5
Nov. 17 (Sat) 10:30-12:00	Recent advances in the management of hepatocellular carcinoma	101
Chairperson(s)	Joong Won Park (Goyang), Jose D Sollano (Manila)
10:30-10:50	Multidisciplinary approach in HCC treatment: various combination strategies and new emerging MTAs in HCC treatment	Masao Omata (Tokyo)
10:50-11:10	Application of new local ablation therapies in HCC: microwave RFA, cryotherapy, etc	Hyunchul Rhim (Seoul)
11:10-11:30	Comparision of transarterial approaches in HCC treatment: conventional TACE, DEB-TACE vs TARE 혹은 Conventional TACE versus new upcoming transarterial treatments in HCC?	Jin Wook Chung (Seoul)
11:30-11:50	Immunotherapeutic approaches beyond molecular targeted agents in HCC	Thomas Yau (Hong Kong)
11:50-12:00	Q&As

Symposium GI-7 (UG)
Nov. 17 (Sat) 10:30-12:00	GERD: new diagnostic approach and management in 2018	103
Chairperson(s)	Sabine Roman (Lyon), Young-Tae Bak (Seoul)
14:00-14:20	Pathophysiology of GERD: what’s new in 2018 ?	John E. Pandolfino (Chicago)
14:20-14:40	Novel diagnostic approach of GERD: From Ascona to Lyon consensus	Sabine Roman (Lyon)
14:40-15:00	The risk and benefits of long-term use of PPIs	TBA
15:00-15:20	Potassium-competitive acid blockers (P-CAB): Advanced therapeutic option for GERD	TBA
15:20-15:30	Q&As

Symposium EN-8 (PB)
Nov. 17 (Sat) 10:30-12:00	Toward the new era of pancreatobiliary endoscopy	104
Chairperson(s)	Sung-Koo Lee (Seoul), Bing Hu (Shanghai)
10:30-10:50	Best way of EUS-guided Tissue acquisition	Eun Young Kim (Daegu)
10:50-11:10	Current EUS-guided local therapy for PB tumor	Dong Wan Seo (Seoul)
11:10-11:30	Optimal EUS-guided drainage in PB disease.	TBA
11:30-11:50	Endoscopic treatment of biliary tract cancer; RFA & PDT	D. Nageshwar Reddy (Hyderabad)
11:50-12:00

Symposium SM-2
Nov. 17 (Sat) 10:30-12:00	Updates on liver transplantation	105
Chairperson(s)	Kyung Suk Suh (Seoul), TBA (TBA), Boon Koon Yoong (Kuala Lumpur)
10:30-10:50	How to decide when to go for liver transplantation	Ray W. Kim (Stanford)
10:50-11:10	Laparoscopic donor hepatectomy; safe and feasible?	Kwang Woong Lee (Seoul)
11:10-11:30	Expanding the indication; tumor and patient factor	Kenneth Chok (Hong Kong)
11:30-11:50	Expanding the indication; overcoming the donor shortage problems	TBA
11:50-12:00	Q&As

Symposium EN-9 (LG)
Nov. 17 (Sat) 10:30-12:00	Screening and diagnosis of colon cancer: current and future	202
Chairperson(s)	Dong Soo Han (Guri), Hermann Brenner (Heidelberg), Tibor Gyokeres (Budapest)
10:30-10:50	Screening based on fecal test: From blood to DNA	Young-Seok Cho (Seoul)
10:50-11:10	Role of CT colonography for screening method	Min Joo Kim (Seoul)
11:10-11:30	Screening colonoscopy: German experiences	Hermann Brenner (Heidelberg)
11:30-11:50	Artificial intelligence for endoscopic diagnosis of colorectal neoplasia	Yuichi Mori (Tokyo)
11:50-12:00	Q&As

Symposium LV-6
Nov. 17 (Sat) 14:00-15:30	Recent changes in the diagnosis and management of liver cirrhosis complication	101
Chairperson(s)	Barjesh C Sharma (New Delhi), Soon Koo Baik (Wonju)
14:00-14:20	Evolving definition and treatment paradigms of acute-on-chronic liver failure	Shiv K. Sarin (New Delhi)
14:20-14:40	Minimal/overt hepatic encephalopathy: diagnostic tools, who should be treated, and how	Ray W. Kim (Stanford)
14:40-15:00	Management of refractory ascites	Ashish Kumar (New Delhi)
15:00-15:20	Recent advances in the management of variceal bleeding	Yeon Seok Seo (Seoul)
15:20-15:30	Q&As

Symposium GI-8 (LG)
Nov. 17 (Sat) 14:00-15:30	What are the special issues of IBD in Asians?	102
Chairperson(s)	Mamoru Watanabe (Tokyo), Hyo Jong Kim (Seoul)
14:00-14:20	Pathophysiologic mechanisms: Genetics and serology in Asian IBD patients	Byong Duk Ye (Seoul)
14:20-14:40	Differential diagnosis of IBD and IBD mimics in Asia	Shu Chen Wei (Taipei)
14:40-15:00	Prognostication of Asian IBD patients: Different from Westerns?	Zhihua Ran (Shanghai)
15:00-15:20	Therapueutic algorithm in Asia vs. Western: Similarities and differences	Katsuyoshi Matsuoka (Tokyo)
15:20-15:30	Q&As

Symposium EN-10 (UG)
Nov. 17 (Sat) 14:00-15:30	Endoscopic treatment for EGJ diseases	103
Chairperson(s)	TBA (TBA), John E. Pandolfino (Chicago)
10:30-10:50	POEM in achalasia: Redo-POEM after failed POEM	TBA
10:50-11:10	Beyond achalasia in POEM: hypercontractile esophageal disorders and gastroparesis	Hwoon-Yong Jung (Seoul)
11:10-11:30	Endoscopic treatment of GERD	John E. Pandolfino (Chicago)
11:30-11:50	Surgical treatment of GERD and Achalasia	Philip Chiu (Hong Kong)
11:50-12:00	Q&As

Symposium-Nursing
Nov. 17 (Sat) 14:00-15:30	Current hot topic	104
Chairperson(s)	Hee Hyuk Im (Seoul), Hui-jun Xi (Shanghai)
14:00-14:20	Endoscope reprocessing: trend, standard, process innovation	Ken Yoshimura (Tokyo)
14:20-14:40	Nursing of Sedative endoscopy	Mei Yin Wong (Hong Kong)
14:40-15:00	The effect of microbiology detection in endoscopic quality control	Hui-jun Xi (Shanghai)
15:00-15:20	Fecal microbiota transplantation	Woo Joo Noh (Seoul)
15:20-15:30	Q&As

Symposium EN-11 (PB)
Nov. 17 (Sat) 14:00-15:30	Management of pain in chronic pancreatitis: An update	202
Chairperson(s)	Yong-Tae Kim (Seoul), Yousuke Nakai (Tokyo)
14:00-14:20	overview of pain mechanism and medical management of chronic pancreatitis	Tae Yoon Lee (Seoul)
14:20-14:40	endoscopic treatment of painful chronic pancreatitis (stricture and stone)	D. Nageshwar Reddy (Hyderabad)
14:40-15:00	Surgical treatment of painful chronic pancreatitis	Joon Seong Park (Seoul)
15:00-15:20	case discussion	Jae Hee Cho (Incheon)
15:20-15:30	Q&As

Symposium GI-9 (GI Cancer)
Nov. 17 (Sat) 14:00-15:30	Emerging armamentarium for the management of GI cancer	203
Chairperson(s)	TBA (TBA), Myung Hwan Noh (Busan)
14:00-14:20	Liquid biopsies: technology overview and clinical implications	Dong Uk Kim (Yangsan)
14:20-14:40	Revisiting an old weapon: HIPEC for GI cancer	Seung Hyuk Baik (Seoul)
14:40-15:00	Immune therapy: Is this ready for use in GI cancer?	Yusuke Hashimoto (Kashiwa)
15:00-15:20	Proton beam therapy or Particle beam therapy	Tae Hyun Kim (Goyang)
15:20-15:30	Q&As

Symposium GI-10 (UG)
Nov. 17 (Sat) 16:00-17:30	What clinicians need to know in ROME IV?	101
Chairperson(s)	Kentaro Sugano (Shimotsukei), Justin C.Y. Wu (Hong Kong)
16:00-16:20	Introduction and overview	Nicholas Talley (Callaghan)
16:20-16:40	Esophageal disorders	Hiroto Miwa (Nishinomiya)
16:40-17:00	Gastroduodenal disorders	Nicholas Talley (Callaghan)
17:00-17:20	Bowel disorders	Suck Chei Choi (Iksan)
17:20-17:30	Q&As

Symposium GI-11 (UG)
Nov. 17 (Sat) 16:00-17:30	Emerging issues in colorectal cancer screening in Asian-Pacific region	102
Chairperson(s)	Khean-Lee Goh (Kuala Lumpur), Uri Ladabaum (Stanford)
16:00-16:20	Colorectal cancer screening guidelines and practice in Asia-Pacific	Hyun-Soo Kim (Wonju)
16:20-16:40	Recent updates in biological markers in colorectal cancer screening	Joseph JY Sung (Hong Kong)
16:40-17:00	Obstacles and inequities in colorectal cancer screening in Asian-Pacific regions	TBA
17:00-17:20	Cost-effectiveness of colorectal cancer screening	Hermann Brenner (Heidelberg)
17:20-17:30	Q&As

AI Advances Endoscopy
Nov. 17 (Sat) 16:00-17:30	Artificial intelligence advances endoscopy	103
Chairperson(s)	Mahesh Goenka (Kolkata), Hisao Tajiri (Tokyo)
16:00-16:20	Convolutional neural network technology for polyp detection	Namkug Kim (Seoul)
16:20-16:40	Computer-aided analysis for polyp classification	Peng-Jen Chen (Taipei)
16:40-17:00	Computer-aided system (EndoBRAIN) for polyp characterization	Yuichi Mori (Tokyo)
17:00-17:20	Endocytoscopy	TBA
17:20-17:30	Q&As

Symposium-Nutrition
Nov. 17 (Sat) 16:00-17:30	Advances in nutritional therapy	104
Chairperson(s)	Cho Hyun Park (Seoul), TBA (TBA)
16:00-16:20	Nutritional modulation of immune function	Jae Hak Kim (Goyang)
16:20-16:40	Immune modulating enteral & parenteral nutrition support (formula)	TBA
16:40-17:00	Nutritional support for surgical patients	In Kyu Lee (Seoul)
17:00-17:20	Nutritional support for critically ill patients	TBA
17:20-17:30	Q&As

Symposium SM-3
Nov. 17 (Sat) 16:00-17:30	Approaches to the Improving Survival of Advanced Colorectal Cancer	105
Chairperson(s)	TBA (TBA), Michael Li (Hong Kong)
16:00-16:20	How do we proceed adequate multidisciplinary team? Taiwan experience	David, Tao-Wei Ke (Taichung)
16:20-16:40	Neoadjuvant chemotherapy: Can we omit radiation therapy?	Jung-Myun Kwak (Seoul)
16:40-17:00	RFA: a non-surgical alternative for colorectal liver metastasis	Dong Ho Lee (Seoul)
17:00-17:20	Optimal application of HIPEC for colorectal cancer with peritoneal carcinomatosis	Wai Lun Law (Hong Kong)
17:20-17:30	Q&As

Symposium EN-12 (PB)
Nov. 17 (Sat) 16:00-17:30	Recent progress in management of difficult CBD stone removal	202
Chairperson(s)	Chang Duck Kim (Seoul), TBA (TBA), Tibor Gyokeres (Budapest)
16:00-16:20	Current status of EPLBD in Korea	Seok Jeong (Incheon)
16:20-16:40	What's new in peroral cholangioscopy and EUS-guided therapy for CBD stone management?	Yousuke Nakai (Tokyo)
16:40-17:00	Laparoscopic approach for difficultr CBD stone management	TBA
17:00-17:20	Endoscopic management of recurrent CBD stones: how to minimize the risk of recurrence?	Sang Hyub Lee (Seongnam)
17:20-17:30	Q&As

Symposium GI-12 (Editor)
Nov. 17 (Sat) 16:00-17:30	An editor’s view point	203
Chairperson(s)	Young S. Kim (San Francisco), Sang Woo Lee (Seoul)
16:00-16:20	Things to consider before submitting a manuscript	Moo In Park (Busan)
16:20-16:40	How to write an attractive abstract	Richard Peek (Nashville)
16:40-17:00	How to write a reviewer report	Eun Young Kim (Daegu)
17:00-17:20	Common reasons for rejection	Emad El-Omar (Kogarah)
17:20-17:30	Q&As

Symposium SM-4
Nov. 18 (Sun) 08:30-10:00	Metablic & bariatric surgery	101
Chairperson(s)	TBA (TBA), John Wong (Hong Kong)
08:30-08:50	Surgical techniques of bariatric surgery: gastric band, sleeve gastrectomy, and gastric bypass	Chih-Kun Huang (Taichung)
08:50-09:10	Management of postoperative complications and bariatric emergencies	TBA
09:10-09:30	Management for treatment failure with bariatric medication	Min Young Cho (Seoul)
09:30-09:50	Long-term follow up and management of nutritional deficiency after bariatric surgery	TBA
09:50-10:00	Q&As

Symposium EN-13 (LG)
Nov. 18 (Sun) 08:30-10:00	Recent advances in radiologic and endoscopic monitoring of IBD	103
Chairperson(s)	Takanori Kanai (Tokyo), Dong Soo Han (Guri)
08:30-08:50	Cutting edge of radilogic evaluation of IBD	Se Hyung Kim (Seoul)
08:50-09:10	Endoscopic grading systems in IBD	Vineet Ahuja (New Delhi)
09:10-09:30	Management of colorectal dysplaisa in IBD	Kenji Watanabe (Nishinomiya)
09:30-09:50	Clinical monitoring of pediatric IBD	Yen-Hsuan Ni (Taipei)
09:50-10:00	Q&As

Best of DDW 1
Nov. 18 (Sun) 08:30-10:00	Best of DDW 01	104+105
Chairperson(s)	Myungkyu Choi (Seoul), Timothy Wang (New York)
08:30-08:55	Helicobacter pylori	Richard Peek (Nashville)
08:55-09:20	Functional GI disorder and microbiome	Emad El-Omar (Kogarah)
09:20-09:45	NSAIDs and peptic ulcer bleedin	TBA
09:45-10:00	Q&As

Symposium GI-13 (UG)
Nov. 18 (Sun) 10:30-12:00	Recent issues in diagnostic and therapeutic endoscopy	101
Chairperson(s)	TBA (TBA), Kenshi Yao (Fukuoka)
08:30-08:50	E-learning system for increasing diagnostic performance in early gastric cancer	Kenshi Yao (Fukuoka)
08:50-09:10	Robot-assisted endoscopic resection	Khek?Yu Ho (Singapore)
09:10-09:30	Quality of ESD: It's time to look back	TBA
09:30-09:50	Satety of endoscopic treatment for GISTs	TBA
09:50-10:00	Q&As

Symposium GI-14 (UG)
Nov. 18 (Sun) 10:30-12:00	Current understanding of peptic ulcer disease	103
Chairperson(s)	Jaw-Town Lin (Taipei), Yong Chan Lee (Seoul), Ian Roberts-Thomson (Adelaide)
08:30-08:50	Pathophysiology and treatment of peptic ulcer	TBA
08:50-09:10	Helicobacter-negative peptic ulcer: the prevention and treatment	Khien Vu Van (Hanoi)
09:10-09:30	GI bleeding in the era of direct oral anticoagulants	Akiko Shiotani (Tokyo)
09:30-09:50	Endoscopic management of peptic ulcer bleeding: recent update	Sunny H. Wong (Hong Kong)
09:50-10:00	Q&As

Best of DDW 2
Nov. 18 (Sun) 10:30-12:00	Best of DDW 02	104+105
Chairperson(s)	Won Ho Kim (Seoul), Timothy Wang (New York)
10:30-10:55	Novel endoscopy	Yuichi Mori (Tokyo)
10:55-11:20	Colorectal cancer	Uri Ladabaum (Stanford)
11:20-11:45	Inflammatory bowel disease	TBA
11:45-12:00	Q&As

Symposium LV-7
Nov. 18 (Sun) 13:30-15:00	Recent advances in liver diseases	101
Chairperson(s)	Osamu Yokosuka (China), Moon Seok Choi (Seoul)
13:30-13:50	Autoimmune hapatitis and primary biliary cholangitis	TBA
13:50-14:10	Alcoholic liver disease and fecal transplant	Shiv K. Sarin (New Delhi)
14:10-14:30	Cholestatic liver disease	Jidong Jia (Beijing)
14:30-14:50	Update in drug induced liver injury	Harshad?Devarbhavi (Bengaluru)
14:50-15:00	Q&As

Symposium GI-15 (LG)
Nov. 18 (Sun) 13:30-15:00	IBS: update 2018	103
Chairperson(s)	Minhu Chen (Guangzhou), Oh Young Lee (Seoul)
13:30-13:50	Low FODMAP diet: what we know in 2018	Peter R. Gibson (Melbourne)
13:50-14:10	Post-infectious IBS: its mechanism and clinical course	Hyo Jin Park (Seoul)
14:10-14:30	Psychosomatic approach for IBS	Shin Fukudo (Sendai)
14:30-14:50	Microbiota in IBS: friend or foe?	Eamonn Quigley (Houston)
14:50-15:00	Q&As

Symposium PB-5
Nov. 18 (Sun) 13:30-15:00	Recent advances in malignant pancreatobiliary diseases	104
Chairperson(s)	Dadang Makmun (Depok), Si Young Song (Seoul)
13:30-13:50	How to find out the early detection of pancreatobiliry cancer	Khek?Yu Ho (Singapore)
13:50-14:10	Optical endoscopic management of Borderline non-resectable pancreatic cancer	TBA
14:10-14:30	Optical management of borderline resectable pancreatic cancer	Hidenori Takahashi (Osaka)
14:30-14:50	Current Status and Future Directions in Chemotherapy for pancreatiBiliary Tract Cancer"	Seung Woo Park (Seoul)
14:50-15:00	Q&As